by shannon | Feb 21, 2023 | Articles
Cell line development insight boosts active protein productivity more than five times Q-Sera, an internationally recognized biotech innovator engaged Bora’s team to develop and manufacture an innovative active protein, RAPClot™ (ecarin), a key component of its...
by shannon | Feb 15, 2023 | Articles
Importance of good flow Good powder flow is particularly important when manufacturing tablets and capsules because rapid and accurate filling of the tablet die or capsule body is essential to achieve consistent weights, and thus, a consistent drug dose. When powdered...
by shannon | Feb 7, 2023 | News and Events, Press Mentions
Read Pharma Manufacturing’s feature article entitled “Built to Thrive: Three CDMOs that set themselves up to flourish” Published on February 7, 2023 Thank you Pharma Manufacturing and author Karen Longhauser Pharma Manufacturing’s feature...
by shannon | Jan 23, 2023 | Press Mentions
Bora Pharmaceuticals is mentioned as “the largest pharmaceutical group by volume in Taiwan” in 2022 after completing the company’s “landmark acquisition” of TWi Pharmaceuticals. Published in the online version of Generics Bulletin....
by shannon | Nov 10, 2022 | News and Events, Press Mentions
Fierce Pharma features a discussion with CEO, Bobby Sheng in an article entitled “After Bora’s biologics debut, CEO outlines quest to join ranks of top CDMOs”. Published on November 10, 2022Thank you Fierce Pharma and author Fraiser Kansteiner...
